News Celgene broadens immunology presence with Anokion deal Biotech specialises in autoimmune disorder drugs.
News US fines Teva $519m over foreign bribery charges Teva admits it bribed officials in Russia, Ukraine and Mexico.
News Alkermes closing in on Biogen with MS rival ALKS 8700 may have fewer side effects than Tecfidera.
News Apitope to develop MS drug, Merck KGaA tie-up ends Anglo-Belgian biotech will continue clinical development.
News Biogen takes on Tecfidera adherence issues Company hopes to coach patients with stomach side-effects.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
